bonebiologics.com - BBLG Profit before deduction of interest, taxes, depreciation and amortization
Bone Biologics (BBLG) does not pay dividends, focusing instead on minimizing scientific risks through the creation of proteins for bone regeneration. The volume of operating cash flow confirms its investment attractiveness, while the 0.00 metric indicates the status of current efficiency. The business demonstrates macro-resilience due to stable demand for skeletal surgery, growing exclusively through internal R&D without utilizing M&A transactions.
Summary analytical data breakdowns for Bone Biologics Corp (BBLG)
- stock value and consensus price forecast:
- issuer market value details:
- book capitalization indicators:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Bone Biologics|BBLG - Long-Term Debt to Equity|Short-Term Debt to Equity Ratio Bone Biologics Corp.|BBLG - Company Aggregate Debts|Debts to Book Value Bone Biologics|BBLG - Company Long-Term Debts|Company Short-Term Indebtedness Bone Biologics|Interim Coverage Ratio bonebiologics.com
- earnings and market multiples details:
BBLG - Net Profit|Future Profit Bone Biologics|BBLG - P/E Multiple|Forward P/E Multiple bonebiologics.com|BBLG - Price/Earnings to Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bone Biologics|BBLG - Operating profit before deduction of amortization|Earnings per share for the trailing year Bone Biologics|BBLG - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months bonebiologics.com|BBLG - Earnings per share growth in current year|Net earnings per one share growth forecast for next year Bone Biologics
Summary company analytics:Bone Biologics
The development of the NELL-1 protein for bone regeneration requires significant expenditures, making cash flow control critical for Bone Biologics (BBLG). By analyzing operating earnings dynamics, an investor can identify the net cash inflow before taxes and interest, which allows for an assessment of the business's internal resilience and its ability to withstand market cost pressures during the clinical trial period.
Who Bone Biologics competes with
Operating income before deduction of amortization Boston Scientific Corporation Inc. (BSX)|EW: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization RMD|PODD: Operating profit EBITDA|Profit before interest, taxes and amortization Zimmer (ZBH)|COO (CooperVision) - Operating profit EBITDA|Operating profit before amortization ALGN (Align Corp)|Operating profit before deduction of amortization GMED (Globus Medical, Inc.)|TMDX (TransMedics Group, Inc.) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Alphatec ATEC|AORT - Operating profit before deduction of amortization|DJO Global - Operating profit EBITDA|Profit before interest, taxes and amortization Integra LifeSciences Inc.|ESTA: Operating profit EBITDA|Operating profit before amortization BBNX|IRMD (IRADIMED) - Operating profit EBITDA|Embecta Corp (EMBC) - Operating income before deduction of amortization|Operating profit EBITDA TNDM|Operating profit before deduction of amortization Axogen Surgical AXGN|Operating profit EBITDA SIBN (SI-BONE, Inc.)|Operating profit EBITDA orthofix.com OFIX|BVS - Profit before payment of interest, taxes and amortization|KIDS: Profit before payment of interest, taxes and amortization|TMCI (Treace Medical) - Operating profit before deduction of amortization|Strata Medical - Income before deduction of interest, taxes and amortization|CARL (Carlsmed Inc) - Operating profit EBITDA|Profit before interest, taxes and amortization rxsight.com RXST|Profit before payment of interest, taxes and amortization ClearPoint Neuro, Inc. (CLPT)|Stereotaxis Inc (STXS) - Operating profit before depreciation charges|NeuroStar - Operating profit before deduction of amortization|Operating profit EBITDA Sight Sciences Inc SGHT|Orchestra BioMed, Inc. - Operating profit EBITDA|Operating income before deduction of amortization Anika Therapeutics ANIK|InspireMD (NSPR) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ZJYL (Jin Medical)|Profit before payment of interest, taxes and amortization Vivani Medical Inc|Operating profit before deduction of amortization Xtant Medical Inc (XTNT)|Operating profit EBITDA NMTC|MODD - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Myomo MYO|COCH: Operating profit before amortization|VVOS: Operating profit before deduction of amortization|enVVeno Corp - Company profit before taxes, interest and amortization|SINT: Operating profit EBITDA|TNON (tenonmed.com) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Lifeward|Profit before interest, taxes and amortization Autonomix AMIX|Profit before payment of interest, taxes and amortization INVO Bioscience, Inc. (IVF)|Axonics, Inc - Operating profit before amortization|Operating profit EBITDA BIOL (BIOLASE, Inc.)|Dynatronics Corp (DYNT) - Profit before interest, taxes and amortization|FNA: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization INVO (INVO Bioscience, Inc.)
